LifeStance Therapists & Psychiatrists Harrisburg
4201 Crums Mill Road, Suite 200, Harrisburg
4.6(173 Google reviews)
United States
3 listed treatment centers serving Harrisburg and the surrounding area.
4201 Crums Mill Road, Suite 200, Harrisburg
4.6(173 Google reviews)
4201 Crums Mill Road, 200, Harrisburg
5.0(32 Google reviews)
3540 North Progress Avenue, 209, Harrisburg
The cost of SPRAVATO® treatment in Harrisburg depends on your insurance benefits, the treatment setting, and your prescribed schedule. Both the medication and the visit for supervised administration and monitoring may be billed. Ask for an estimate that separates these services rather than assuming one quoted charge includes everything.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials before reviewing coverage. Ask your prescribing clinician to help gather medication names, doses, treatment dates or durations, and information about your response or side effects. The treatment center can explain which records your plan requests and who submits the authorization. Authorization does not necessarily mean you will have no out-of-pocket costs.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Pennsylvania Medicaid coverage also depends on the plan and applicable requirements. The three Harrisburg listings in this directory are marked as not accepting Medicare or Medicaid; confirm current participation directly before scheduling.
Manufacturer savings programs exist for eligible commercially insured patients, but these programs are not for people using government insurance. Ask about current eligibility rules and which charges assistance may address; do not assume monitoring costs are included.
Before starting, ask the center and insurer:
SPRAVATO® is given only in a healthcare setting certified through the SPRAVATO® REMS program. You administer the nasal spray yourself under direct observation; it is never supplied for home use. This directory lists three Harrisburg locations offering Spravato, but their REMS certification status is not confirmed in the listing data. Verify certification directly before booking.
The typical labeled schedule begins with twice-weekly treatment during weeks 1–4, followed by weekly treatment during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule that is appropriate for you, so avoid treating this pattern as a guaranteed personal timetable.
Allow more than two hours at the center. Monitoring alone lasts at least two hours after each dose, and check-in, preparation, and assessment may add time. Ask how much time to reserve and whether longer observation could be needed. When arranging time off work, account for the appointment, transportation, and the restriction on driving or operating machinery afterward.
You need someone else to take you home. Do not drive until the next day after a restful sleep. Arrange a trusted driver in advance, make a backup plan, and ask the center about its pickup and escort requirements before relying on a taxi or rideshare.
If a future search shows no Harrisburg center, or local options cannot accommodate you, this directory also lists centers in Lancaster, York, Reading, Allentown, State College, Altoona, Philadelphia, and Pittsburgh. These listings do not establish certification or appointment availability. Confirm both, and consider whether repeated trips and dependable rides would be manageable before choosing a location.
This directory lists three Harrisburg locations offering SPRAVATO®, but their REMS certification status is not confirmed in the available data. Contact a location directly and ask whether it is currently certified to provide treatment through the Spravato REMS program. Also ask whether it is accepting new patients, what records are needed, and whether it accepts your insurance.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your treatment history, health, and safety considerations; a diagnosis alone does not guarantee eligibility.
Coverage depends on your plan and the treatment setting. Medicare Part B or Part D and Pennsylvania Medicaid may cover treatment in some circumstances. However, the three Harrisburg listings here are marked as not accepting Medicare or Medicaid. Confirm current participation with the center and benefits with your insurer. Ask separately about coverage for the medication and the supervised monitoring visit.
You self-administer the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including checking for sedation, dissociation, breathing problems, and blood pressure increases. The total appointment may take longer. Someone else must take you home, and you must not drive or operate machinery until the next day after a restful sleep.
Important risks include sedation, dissociation, respiratory depression, and increased blood pressure. Dissociation can feel like being disconnected from yourself or your surroundings. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your medical history, medications, and substance use honestly so the clinician can assess safety and explain monitoring.
Do not wait for a treatment appointment if you need immediate help. Call or text 988 for crisis support, or call 911 in an emergency. Although Spravato has an approved use for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, it has not been shown to prevent suicide or reduce suicidal thoughts or behavior. It does not replace hospitalization when clinically needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.